Gallen Triana‐Baltzer

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease

Shorena Janelidze, Divya Bali, Nicholas J. Ashton et al. · Brain · 2022 · 505 citations · Full text

Life Sciences, Biochemistry, Dementia +16

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

Shorena Janelidze, Erik Stomrud, Ruben Smith et al. · Nature Communications · 2020 · 453 citations · Full text

Medicine, Neurology, Neuroscience +14

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Bruna Bellaver, Guilherme Povala, Pâmela C.L. Ferreira et al. · Nature Medicine · 2023 · 310 citations · Full text

Medicine, Neurology, Neuroscience +16

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography

Joseph Therriault, Marie Vermeiren, Stijn Servaes et al. · JAMA Neurology · 2022 · 265 citations · Full text

Life Sciences, Neurology, Neuroscience +17

A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

Wagner S. Brum, Nicholas Cullen, Shorena Janelidze et al. · Nature Aging · 2023 · 241 citations · Full text

Medicine, Neurology, Neuroscience +17